The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: A prospective randomized clinical trial

International Journal of Dermatology

Volumn 45, Issue 3, 2006, Pages 245-250

  Boztepe, Gonca ^a   Karaduman, Ayşen ^a   Şahin, Sedef ^a   Hayran, Murat ^a   Kölemen, Fikret ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; LIFE TABLE METHOD; MAINTENANCE THERAPY; MALE; PROBABILITY; PROSPECTIVE STUDY; PRURITUS; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 33644781678     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02398.x     Document Type: Article

References (20)

1. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51-59.
2. Spuls PI, Witkamp L, Bossuyt PMM, et al. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 1997; 137: 943-949.
3. Spuls PI, Bossuyt PMM, van Everdingen JJE, et al. The development of practice guidelines for the treatment of severe plaque form psoriasis. Arch Dermatol 1998; 134: 1591-596.
4. Parrish JA, Jaenicke KF. Action spectrum for psoriasis. J Invest Dermatol 1981; 76: 359-362.
5. van Weelden H, De la Faille BB, Young E, et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
6. Green C, Ferguson J, Lakshmipathi T, et al. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-696.
7. Coven TR, Burack LH, Gilleaudeau P, et al. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133: 1514-1522.
8. Picot E, Meunier L, Picot-Debeze MC, et al. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992; 127: 509-512.
9. Tanew A, Fijan S, Hönigsman H. Halfside comparison study on narrow-band UVB phototherapy versus photochemotherapy (PUVA) in the treatment of psoriasis. J Invest Dermatol 1996; 106: 841-846.
10. Stern RS. Narrowband UV-B and psoriasis. Arch Dermatol 1997; 133: 1587-1588.
11. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432.
12. Melski JW, Tanenbaum L, Parrish JA, et al. Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 1989; 92: 153S-156S.
13. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: A randomized study. J Am Acad Dermatol 1986; 15: 546-552.
14. Gordon PM, Saunders PJ, Diffey BL, et al. Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1998; 139: 811-814.
15. Fredriksson T, Petterson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 137: 238-244.
16. Stern RS, Beer JZ, Mills DK. Lack of consensus among experts on the choice of UV therapy for psoriasis. Arch Dermatol 1999; 135: 1187-1192.
17. van Weelden H, De la Faille BB, Young E, et al. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol (Stockh) 1990; 70: 212-215.
18. Collins P, Wainwright NJ, Amorin I, et al. 8-MOP PUVA for psoriasis: A comparison of minimal phototoxic dose-based regimen with a skin-type approach. Br J Dermatol 1996; 135: 248-254.
19. Gordon KB, Papp KA, Hamilton TK, et al. Efalizumab for patients with moderate to severe plaque psoriasis: A randomized controlled trial. J Am Med Assoc 2003; 290: 3073-3080.
20. Weinberg JM. An overview of infliximab, etanercept, efalizumab, an alefacept as biologic therapy of psoriasis. Clin Ther 2003; 25: 2487-2505.